Hsp90 is a potential target to prevent protein accumulation in multiple neurodegenerative proteinopathies, including tauopathies, amyloid beta [76,77], poly-glutamine repeat expansion disorders, and Parkinson’s disease [78–80]. Here, HSP90AA1 is linked to tauopathy.